Skip to content
Screener

Pfizer PFE Restructuring Reserve

Discontinued — last reported Q3 '25

Restructuring Reserve at other companies

Viatris logo
ViatrisVTRS
$152.4M+17.5%
Organon logo
OrganonOGN
$32M-64.8%

Segments

By segment

See full
Biopharma$3.7B+54.2%

Other financials

Income statement

See full
Revenue$15.0B+2.6%
Gross profit$10.9B+0.6%
Net income-$248.0M-109%
EPS (diluted)-$0.04-108%

Balance sheet

See full
Cash & equivalents$1.8B+18.8%
Total debt$64.4B+4.9%
Total equity$90.1B-0.3%
Total assets$207.62B-0.2%

Cash flow

See full
Operating cash flow$2.6B+12.0%
CapEx$436.0M-22.7%
Free cash flow$2.2B+23.0%

Valuation

See full
Market cap$149.33B+9.8%
Enterprise value$212B+9.2%
P/E16.8×—
P/S2.3×+0.2×

Profitability

See full
Gross margin73.2%+1.1pp
Net margin15.7%—
FCF margin18%+8.8pp

Returns & leverage

See full
Return on equity10.6%—
Debt / equity0.7×0.0×
Current ratio1.2×0.0×

Where this comes from

Reported directly by Pfizer in its filing.

Tagged under the XBRL concept us-gaap:RestructuringReserve.

The source filing: Pfizer’s 10-Q, filed November 4, 2025.

Filed
Nov 4, 2025
Fiscal quarter
Q3 FY2025
Calendar quarter
Q3 2025
Accession
0000078003-25-000150
(MILLIONS)Employee Termination CostsAsset Impairment ChargesExit CostsAccrual
Balance, December 31, 2024(a)$2,046—$74$2,120
Provision36032896784
Utilization and other(b)(724)(328)(15)(1,067)
Balance, September 28, 2025(c)$1,682—$155$1,836

Item 1.

FAQ

What is Pfizer's restructuring reserve?
Pfizer (PFE) reported restructuring reserve of $1.84B in Q3 2025.
How has Pfizer's restructuring reserve changed year-over-year?
Pfizer's restructuring reserve decreased by 13.9% year-over-year, from $2.13B to $1.84B.
What is the long-term trend for Pfizer's restructuring reserve?
Over 4 years (2020 to 2024), Pfizer's restructuring reserve has grown at a 27.7% compound annual growth rate (CAGR), from $798M to $2.12B.
What does restructuring reserve mean?
This represents the estimated liability for costs associated with formal restructuring plans, such as severance, facility closures, or asset impairments. It reflects management's commitment to operational efficiency and strategic realignment. These reserves are drawn down as the restructuring activities are executed.

Ask your AI about Pfizer's restructuring reserve.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude